PULSE BIOSCIENCES, INC. — Director's Dealing 2017

May 3, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2017-04-28

Reporting Person: DUGGAN ROBERT W (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-04-28	Common Stock	P	25000	$23.85	Acquired	2958579	Direct
2017-05-01	Common Stock	P	19348	$23.812	Acquired	2977927	Direct
2017-05-02	Common Stock	P	5000	$23.40	Acquired	2982927	Direct
2017-04-28	Common Stock	P	35000	$24.00	Acquired	35000	Indirect

Footnotes

F1: This is the weighted average purchase price of the shares, which ranged from $23.362 to $23.989 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

F2: Shares are held by Genius Accelerated LLC, of which the Reporting Person is the sole member and beneficiary.